Over a 60-day period, only 1 out of 6 mice implanted with TREM1 KO LCSLCs developed tumors, whereas in the TREM1-positive implants, tumor formation was significantly higher, with 4 out of 6 developing tumors. The gene discussed is TREM1; the disease is neoplasm.